Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Swedish pet supply conglomerate issues undiscounted shares to fund acquisitions -
Scott Bardo is returning to the fold after 10 years with Berenberg
-
German pharmaceuticals platform breaks the ice for large cap listings in Europe this year
-
It could take years to develop a gene therapy to slow aging, but much less for big pharma to scoop up Genflow Biosciences
-
PRA to return to risk-weighted asset-based calculation for Pillar 2A
-
The pandemic has helped the Swiss online pharmacy to boost its business
